wikidata · entity Q113689818
Formulation Development and Optimization of Bioenhanced Sublingual Tablets of Rizatriptan Benzoate to Combat Migraine
scientific article published in 2022description language: enLabelsenDescriptionsen
Statements
P31instance of1 statement
- Q13442814 normal
Names and descriptions in other languages
- enFormulation Development and Optimization of Bioenhanced Sublingual Tablets of Rizatriptan Benzoate to Combat Migrainescientific article published in 2022
Source and licence
Licence CC0-1.0 · source wikidata. Canonical record on Wikidata.
This page shows the entity row the local dump holds; it does not claim the dump is complete. 1 description language stored for this entity.